New Market Report: Global Hepatitis Drugs Market 2015-2019

Hepatitis is an inflammatory condition that occurs due to infection by hepatitis virus. It predominantly affects the liver and also causes damage to other body parts such as digestive system and brain. Apart from viral infections, hepatitis can also be caused by toxic substances, alcohol consumption, and autoimmune diseases. The viruses that cause hepatitis are of several types: A, B, C, D, E, and G. The most common type of hepatitis viruses are A, B, and C. Hepatitis viruses can cause either acute or chronic infections.

Technavio's analysts forecast the global hepatitis drugs market to grow at a CAGR of 17.1% over the period 2014-2019.

Covered in this report

The report includes the present scenario and the growth prospects of the global hepatitis drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of hepatitis.

Technavio's report, Global Hepatitis Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market size and forecast as well as the segmentation. The report includes a discussion of the key vendors operating in this market.

Full Report Details at
- http://www.fastmr.com/prod/1099069_global_hepatitis_drugs.aspx?afid=301

Key regions

* Americas
* APAC
* EMEA

Key vendors

* F. Hoffmann-La Roche
* Gilead Sciences
* GlaxoSmithKline
* Johnson & Johnson
* Merck
* Novartis
* Vertex Pharmaceuticals

Other prominent vendors

* Abbvie
* Achillion Pharmaceuticals
* Bristol-Myers Squibb
* Dynavax Technologies
* Mitsubishi Tanabe Pharma

Key market driver

* Emergence of IFN-free therapies
* For a full, detailed list, view our report

Key market challenge

* Side-effects of current therapy
* For a full, detailed list, view our report

Key market trend

* Collaborations and M&A
* For a full, detailed list, view our report

Key questions answered in this report

* What will the market size be in 2019 and what will the growth rate be?
* What are the key market trends?
* What is driving this market?
* What are the challenges to market growth?
* Who are the key vendors in this market space?
* What are the market opportunities and threats faced by the key vendors?
* What are the strengths and weaknesses of the key vendors?

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

Companies Mentioned in this Report: F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Vertex Pharmaceuticals, Abbvie, Achillion Pharmaceuticals, Bristol-Myers Squibb, Dynavax Technologies, Mitsubishi Tanabe Pharma

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Alcoholic Hepatitis Global Clinical Trials Review, H1, 2015
- Autoimmune Hepatitis Global Clinical Trials Review, H1, 2015
- Hepatitis B Therapeutics in Major Developed Markets to 2021 - Increasing Number of Migrants from High-Prevalence Regions to Drive Market Growth
- Hepatitis C - Pipeline Review, H1 2015
- Global Liver Diseases Therapeutics Market 2015-2019